Venture capital investor says selling shares in early-stage private companies via an auction process can be ‘problematic’.
The NZX-listed industrial hardware producer expects a profit in excess of $28m for year June.
In the short term, enduring low margins mean operations set to be simplified.
The listed company owns Unichem and Life Pharmacies.
Regulator expresses concern at ‘frothiness’ of the market
Investors in a failed forestry scheme suffer slow payouts and money still owing.
Central bank leaves the OCR unchanged but is downbeat on the economic outlook.
Auckland company Aroa Biosurgery to list on ASX on July 30.
As NZ gears up to fight a new wave of offending it is still lacking a financial crime strategy.
The eftpos terminals provider had strong growth in Australia.